Literature DB >> 29596073

The Development of a Machine Learning Inpatient Acute Kidney Injury Prediction Model.

Jay L Koyner1, Kyle A Carey, Dana P Edelson, Matthew M Churpek.   

Abstract

OBJECTIVES: To develop an acute kidney injury risk prediction model using electronic health record data for longitudinal use in hospitalized patients.
DESIGN: Observational cohort study.
SETTING: Tertiary, urban, academic medical center from November 2008 to January 2016. PATIENTS: All adult inpatients without pre-existing renal failure at admission, defined as first serum creatinine greater than or equal to 3.0 mg/dL, International Classification of Diseases, 9th Edition, code for chronic kidney disease stage 4 or higher or having received renal replacement therapy within 48 hours of first serum creatinine measurement.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Demographics, vital signs, diagnostics, and interventions were used in a Gradient Boosting Machine algorithm to predict serum creatinine-based Kidney Disease Improving Global Outcomes stage 2 acute kidney injury, with 60% of the data used for derivation and 40% for validation. Area under the receiver operator characteristic curve (AUC) was calculated in the validation cohort, and subgroup analyses were conducted across admission serum creatinine, acute kidney injury severity, and hospital location. Among the 121,158 included patients, 17,482 (14.4%) developed any Kidney Disease Improving Global Outcomes acute kidney injury, with 4,251 (3.5%) developing stage 2. The AUC (95% CI) was 0.90 (0.90-0.90) for predicting stage 2 acute kidney injury within 24 hours and 0.87 (0.87-0.87) within 48 hours. The AUC was 0.96 (0.96-0.96) for receipt of renal replacement therapy (n = 821) in the next 48 hours. Accuracy was similar across hospital settings (ICU, wards, and emergency department) and admitting serum creatinine groupings. At a probability threshold of greater than or equal to 0.022, the algorithm had a sensitivity of 84% and a specificity of 85% for stage 2 acute kidney injury and predicted the development of stage 2 a median of 41 hours (interquartile range, 12-141 hr) prior to the development of stage 2 acute kidney injury.
CONCLUSIONS: Readily available electronic health record data can be used to predict impending acute kidney injury prior to changes in serum creatinine with excellent accuracy across different patient locations and admission serum creatinine. Real-time use of this model would allow early interventions for those at high risk of acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29596073     DOI: 10.1097/CCM.0000000000003123

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  81 in total

Review 1.  Machine learning, the kidney, and genotype-phenotype analysis.

Authors:  Rachel S G Sealfon; Laura H Mariani; Matthias Kretzler; Olga G Troyanskaya
Journal:  Kidney Int       Date:  2020-04-01       Impact factor: 10.612

2.  Risk Factors for Acute Kidney Injury in Hospitalized Non-Critically Ill Patients: A Population-Based Study.

Authors:  Sami Safadi; Musab S Hommos; Felicity T Enders; John C Lieske; Kianoush B Kashani
Journal:  Mayo Clin Proc       Date:  2020-01-31       Impact factor: 7.616

3.  A Factored Generalized Additive Model for Clinical Decision Support in the Operating Room.

Authors:  Zhicheng Cui; Bradley A Fritz; Christopher R King; Michael S Avidan; Yixin Chen
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

4.  Current Status of Novel Biomarkers for the Diagnosis of Acute Kidney Injury: A Historical Perspective.

Authors:  Benjamin R Griffin; Katja M Gist; Sarah Faubel
Journal:  J Intensive Care Med       Date:  2019-01-17       Impact factor: 3.510

Review 5.  The impact of biomarkers of acute kidney injury on individual patient care.

Authors:  Jay L Koyner; Alexander Zarbock; Rajit K Basu; Claudio Ronco
Journal:  Nephrol Dial Transplant       Date:  2020-08-01       Impact factor: 5.992

6.  Robust clinical marker identification for diabetic kidney disease with ensemble feature selection.

Authors:  Xing Song; Lemuel R Waitman; Yong Hu; Alan S L Yu; David C Robbins; Mei Liu
Journal:  J Am Med Inform Assoc       Date:  2019-03-01       Impact factor: 4.497

7.  Which risk predictors are more likely to indicate severe AKI in hospitalized patients?

Authors:  Lijuan Wu; Yong Hu; Borong Yuan; Xiangzhou Zhang; Weiqi Chen; Kang Liu; Mei Liu
Journal:  Int J Med Inform       Date:  2020-09-11       Impact factor: 4.046

Review 8.  Artificial Intelligence and Surgical Decision-making.

Authors:  Tyler J Loftus; Patrick J Tighe; Amanda C Filiberto; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Parisa Rashidi; Gilbert R Upchurch; Azra Bihorac
Journal:  JAMA Surg       Date:  2020-02-01       Impact factor: 14.766

9.  Machine Learning to Predict Acute Kidney Injury.

Authors:  F Perry Wilson
Journal:  Am J Kidney Dis       Date:  2019-10-31       Impact factor: 8.860

10.  Quality Improvement Goals for Acute Kidney Injury.

Authors:  Kianoush Kashani; Mitchell Howard Rosner; Michael Haase; Andrew J P Lewington; Donal J O'Donoghue; F Perry Wilson; Mitra K Nadim; Samuel A Silver; Alexander Zarbock; Marlies Ostermann; Ravindra L Mehta; Sandra L Kane-Gill; Xiaoqiang Ding; Peter Pickkers; Azra Bihorac; Edward D Siew; Erin F Barreto; Etienne Macedo; John A Kellum; Paul M Palevsky; Ashita Jiwat Tolwani; Claudio Ronco; Luis A Juncos; Oleksa G Rewa; Sean M Bagshaw; Theresa Ann Mottes; Jay L Koyner; Kathleen D Liu; Lui G Forni; Michael Heung; Vin-Cent Wu
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.